Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline and Amantadine in Moderate TBI
NCT03430817Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Dec 2017
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of citicoline, amantadine hydrochloride intravenous solution in traumatic brain injury (TBI), sponsored by Ain Shams University. Started Dec 2017; status: completed.
02
Drugs
citicolineamantadine hydrochloride intravenous solution
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT03430817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03430817.